Use of Shockwave and EMTT Treatment to Improve Erectile Function and Sexual Satisfaction Among Patients with Peyronie’s Disease
Michael Strøm
Michael is an internationally recognized provider of shockwave and extracorporeal magnetotransduction therapy (EMTT) treatments for sexual dysfunction and urological conditions. He is the managing provider of the MS Insight Clinic, one of Denmark’s leading clinics to serve patients with ED and Peyronie’s Disease. Regularly, Michael conducts educational seminars or presents at international conferences regarding shockwave and EMTT treatment protocols for patients with sexual dysfunction and urological conditions. Additionally, Michael serves as the Clinical Director of US Shockwave Education at the Academy of Shockwave Excellence.
This Circle enables healthcare professionals in the evidence-based standardization of effectiveness and safety of shockwave and EMTT treatments for Peyronie’s Disease. This Circle captures validated patient-reported data regarding symptom severity and quality of life before and after shockwave treatment over a 12-month period. The Circle also collects clinically pertinent data, such as patient demographics and shockwave technology specifications, providing valuable insights for clinical decision-making.
Observational, Quality Improvement
- Peyronie’s Disease Questionnaire (PDQ) Scale
- International Index of Erectile Function (IIEF-5)
- EQ-5D
- Longitudinal, real-world safety and efficacy assessment of shockwave and EMTT treatment.
- Participate and benefit from clinically significant registry datasets supporting standards of care for a variety of conditions, including erectile dysfunction, Peyronie’s disease, and chronic pelvic pain.
- Drive superior patient education and engagement.
- Legal/regulatory compliance.
Private
Use of Shockwave and EMTT Treatment to Improve Erectile Function and Sexual Satisfaction Among Patients with Peyronie’s Disease
This Circle enables healthcare professionals in the evidence-based standardization of effectiveness and safety of shockwave and EMTT treatments for Peyronie’s Disease. This Circle captures validated patient-reported data regarding symptom severity and quality of life before and after shockwave treatment over a 12-month period. The Circle also collects clinically pertinent data, such as patient demographics and shockwave technology specifications, providing valuable insights for clinical decision-making.
PDQ Scale, IIEF-5, EQ-5D
- Longitudinal, real-world safety and efficacy assessment of shockwave and EMTT treatment.
- Participate and benefit from clinically significant registry datasets supporting standards of care for a variety of conditions, including erectile dysfunction, Peyronie’s disease, and chronic pelvic pain.
- Drive superior patient education and engagement.
- Legal/regulatory compliance.
Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration
Private